Lipid Modification Database
Tag Content
LipidDB ID
LipidDB-10090-00186
Entry Name
UniProt Accession
Theoretical PI
8.04
Molecular Weight
95640.18
Genbank Protein ID
Genbank Nucleotide ID
Protein Name
Semaphorin-4D
Protein Synonyms/Alias
M-Sema G; Semaphorin-C-like 2; Semaphorin-J; Sema J; CD100;
Gene Name
Sema4d
Gene Synonyms/Alias
Semacl2; Semaj;
Created Date
30-MAY-2000
 Lipid Modification Sites 
 Position   Sequence Form   Peptide   References   Modification Type 
4
Canonical
****MRMCAPVRGLF
[1]
S-Palmitoylation
553
Canonical
MSGDTSSCLDKSKES
[1]
S-Palmitoylation
Organism
Mus musculus (Mouse)
NCBI Taxa ID
10090
Reference
[1] Predicted from GPS-Lipid
Functional Description
Cell surface receptor for PLXN1B and PLXNB2 that plays an important role in cell-cell signaling. Promotes reorganization of the actin cytoskeleton and plays a role in axonal growth cone guidance in the developing central nervous system. Regulates dendrite and axon branching and morphogenesis. Promotes the migration of cerebellar granule cells and of endothelial cells. Plays a role in the immune system; induces B-cells to aggregate and improves their viability (in vitro). Promotes signaling via SRC and PTK2B/PYK2, which then mediates activation of phosphatidylinositol 3-kinase and of the AKT1 signaling cascade. Interaction with PLXNB1 mediates activation of RHOA (By similarity).
Sequence Annotation
Topological domain: 24 733 Extracellular.
Transmembrane: 734 754 Helical.
Topological domain: 755 861 Cytoplasmic.
Domain: 24 500 Sema.
Domain: 502 551 PSI.
Domain: 555 636 Ig-like C2-type.
Protein Length
861 AA.
Protein Sequence
(Canonical)
MRMCAPVRGL FLALVVVLRT AVAFAPVPRL TWEHGEVGLV QFHKPGIFNY SALLMSEDKD  60
TLYVGAREAV FAVNALNISE KQHEVYWKVS EDKKSKCAEK GKSKQTECLN YIRVLQPLSS  120
TSLYVCGTNA FQPTCDHLNL TSFKFLGKSE DGKGRCPFDP AHSYTSVMVG GELYSGTSYN  180
FLGSEPIISR NSSHSPLRTE YAIPWLNEPS FVFADVIQKS PDGPEGEDDK VYFFFTEVSV  240
EYEFVFKLMI PRVARVCKGD QGGLRTLQKK WTSFLKARLI CSKPDSGLVF NILQDVFVLR  300
APGLKEPVFY AVFTPQLNNV GLSAVCAYTL ATVEAVFSRG KYMQSATVEQ SHTKWVRYNG  360
PVPTPRPGAC IDSEARAANY TSSLNLPDKT LQFVKDHPLM DDSVTPIDNR PKLIKKDVNY  420
TQIVVDRTQA LDGTFYDVMF ISTDRGALHK AVILTKEVHV IEETQLFRDS EPVLTLLLSS  480
KKGRKFVYAG SNSGVVQAPL AFCEKHGSCE DCVLARDPYC AWSPAIKACV TLHQEEASSR  540
GWIQDMSGDT SSCLDKSKES FNQHFFKHGG TAELKCFQKS NLARVVWKFQ NGELKAASPK  600
YGFVGRKHLL IFNLSDGDSG VYQCLSEERV RNKTVSQLLA KHVLEVKMVP RTPPSPTSED  660
AQTEGSKITS KMPVASTQGS SPPTPALWAT SPRAATLPPK SSSGTSCEPK MVINTVPQLH  720
SEKTVYLKSS DNRLLMSLLL FIFVLFLCLF SYNCYKGYLP GQCLKFRSAL LLGKKTPKSD  780
FSDLEQSVKE TLVEPGSFSQ QNGDHPKPAL DTGYETEQDT ITSKVPTDRE DSQRIDELSA  840
RDKPFDVKCE LKFADSDADG D                                            861
FASTA
(Canonical)
>LipidDB-10090-00186|O09126
MRMCAPVRGLFLALVVVLRTAVAFAPVPRLTWEHGEVGLVQFHKPGIFNYSALLMSEDKD
TLYVGAREAVFAVNALNISEKQHEVYWKVSEDKKSKCAEKGKSKQTECLNYIRVLQPLSS
TSLYVCGTNAFQPTCDHLNLTSFKFLGKSEDGKGRCPFDPAHSYTSVMVGGELYSGTSYN
FLGSEPIISRNSSHSPLRTEYAIPWLNEPSFVFADVIQKSPDGPEGEDDKVYFFFTEVSV
EYEFVFKLMIPRVARVCKGDQGGLRTLQKKWTSFLKARLICSKPDSGLVFNILQDVFVLR
APGLKEPVFYAVFTPQLNNVGLSAVCAYTLATVEAVFSRGKYMQSATVEQSHTKWVRYNG
PVPTPRPGACIDSEARAANYTSSLNLPDKTLQFVKDHPLMDDSVTPIDNRPKLIKKDVNY
TQIVVDRTQALDGTFYDVMFISTDRGALHKAVILTKEVHVIEETQLFRDSEPVLTLLLSS
KKGRKFVYAGSNSGVVQAPLAFCEKHGSCEDCVLARDPYCAWSPAIKACVTLHQEEASSR
GWIQDMSGDTSSCLDKSKESFNQHFFKHGGTAELKCFQKSNLARVVWKFQNGELKAASPK
YGFVGRKHLLIFNLSDGDSGVYQCLSEERVRNKTVSQLLAKHVLEVKMVPRTPPSPTSED
AQTEGSKITSKMPVASTQGSSPPTPALWATSPRAATLPPKSSSGTSCEPKMVINTVPQLH
SEKTVYLKSSDNRLLMSLLLFIFVLFLCLFSYNCYKGYLPGQCLKFRSALLLGKKTPKSD
FSDLEQSVKETLVEPGSFSQQNGDHPKPALDTGYETEQDTITSKVPTDREDSQRIDELSA
RDKPFDVKCELKFADSDADGD
Gene Ontology
GO:0005615; C:extracellular space; IDA:BHF-UCL
GO:0005887; C:integral component of plasma membrane; IEA:Ensembl
GO:0016020; C:membrane; TAS:BHF-UCL
GO:0005102; F:receptor binding; IPI:MGI
GO:0030215; F:semaphorin receptor binding; IPI:BHF-UCL
GO:0004888; F:transmembrane signaling receptor activity; ISS:UniProtKB
GO:0070486; P:leukocyte aggregation; ISS:UniProtKB
GO:0010693; P:negative regulation of alkaline phosphatase activity; IDA:BHF-UCL
GO:0007162; P:negative regulation of cell adhesion; ISS:UniProtKB
GO:0045668; P:negative regulation of osteoblast differentiation; IMP:BHF-UCL
GO:0050732; P:negative regulation of peptidyl-tyrosine phosphorylation; IDA:BHF-UCL
GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:BHF-UCL
GO:0043931; P:ossification involved in bone maturation; IMP:BHF-UCL
GO:0050772; P:positive regulation of axonogenesis; IDA:MGI
GO:0030335; P:positive regulation of cell migration; IDA:BHF-UCL
GO:0048672; P:positive regulation of collateral sprouting; ISS:UniProtKB
GO:0050731; P:positive regulation of peptidyl-tyrosine phosphorylation; IDA:BHF-UCL
GO:0014068; P:positive regulation of phosphatidylinositol 3-kinase signaling; ISS:UniProtKB
GO:0001934; P:positive regulation of protein phosphorylation; ISS:UniProtKB
GO:0032321; P:positive regulation of Rho GTPase activity; IMP:BHF-UCL
GO:0031344; P:regulation of cell projection organization; ISS:UniProtKB
GO:0008360; P:regulation of cell shape; ISS:UniProtKB
GO:0048814; P:regulation of dendrite morphogenesis; ISS:UniProtKB
GO:0071526; P:semaphorin-plexin signaling pathway; ISS:UniProtKB
GO:1900220; P:semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis; IMP:BHF-UCL
Interpro
InterPro; IPR007110; Ig-like_dom
InterPro; IPR013783; Ig-like_fold
InterPro; IPR003599; Ig_sub
InterPro; IPR016201; Plexin-like_fold
InterPro; IPR002165; Plexin_repeat
InterPro; IPR001627; Semap_dom
InterPro; IPR027231; Semaphorin
InterPro; IPR015943; WD40/YVTN_repeat-like_dom
Pfam
Pfam; PF01437; PSI;
Pfam; PF01403; Sema;
SMART
SMART; SM00409; IG;
SMART; SM00423; PSI;
SMART; SM00630; Sema;
PROSITE
PROSITE; PS50835; IG_LIKE;
PROSITE; PS51004; SEMA;
PRINTS